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Abstract 
In the last three decades, more than 200 monoclonal antibodies have been raised against most 
classes of plant cell wall polysaccharides by different laboratories world-wide. These 
antibodies are widely used to identify differences in plant cell wall components in mutants, 
organ and tissue types, and developmental stages. Despite their importance and broad use, the 
precise binding epitope for only a few of these antibodies has been determined. Here, we use 
a plant glycan microarray equipped with 88 synthetic oligosaccharides to comprehensively 
map the epitopes of plant cell wall glycan-directed antibodies. Our results reveal the binding 
epitopes for 78 arabinogalactan-, rhamnogalacturonan-, xylan-, and xyloglucan-directed 
antibodies. We demonstrate that, with knowledge of the exact epitopes recognized by 
individual antibodies, specific glycosyl hydrolases can be implemented into immunological 
cell wall analyses, providing a framework to obtain structural information on plant cell wall 
glycans with unprecedented molecular precision. 
Introduction 
Plant cell walls are highly complex sophisticated composites largely comprised of 
polysaccharide networks with essential functions in the life cycle of plants. Plant physiology, 
growth, and development all depend on the structure and dynamics of the cell wall (Keegstra 
2010). Moreover, cell wall polysaccharides receive an enormous interest as sources of 
renewable materials and for the production of biofuels (Pauly and Keegstra 2010). To 
enhance the economic viability of biomass as a renewable resource, an increasing number of 
genetically engineered plants with modified cell wall compositions have been generated 
(Loque, Scheller, and Pauly 2015). However, a prerequisite to performing targeted genetic 
modifications is a detailed knowledge of plant cell wall structure and its biosynthesis. 
To characterize these very diverse plant cell wall components and the genes responsible for 
their synthesis, biochemical tools are required that can identify molecular structures in the cell 
wall with high precision. Glycosidic linkage analyses of cell wall extracts can provide 
quantitative information on the abundance of monosaccharides and their linkage types 
(Pettolino et al. 2012). This information can then be used to derive occurrence and structure of 
different polysaccharide classes. However, this method can only be applied to whole organs, 
and thus it remains unclear which tissue and cell types contain the identified polysaccharides. 
To obtain high spatial resolution, a large number of monoclonal antibodies (mAbs) that bind 
distinct classes of cell wall polysaccharides have been developed (Pattathil et al. 2010; 
Classen et al. 2004; McCartney, Marcus, and Knox 2005; Meikle et al. 1994; Ralet et al. 
2010; Willats, Marcus, and Knox 1998). These mAbs are widely used to localize 
polysaccharides in cells and tissues of various plant species (Guillon et al. 2004; Classen et al. 
2004; da Costa et al. 2017), and to characterize mutant plants with alterations in cell wall 
composition (Pacheco-Villalobos et al. 2016; Gendre et al. 2013). Yet, the limited information 
on the precise molecular structures bound by the mAbs has hindered a comprehensive 
interpretation of immunological cell wall analyses.  
Due to the heterogeneity and diversity of glycoforms within polysaccharide classes, the small 
number of well characterized mAbs have the precision with which these molecular probes can 
be used to infer polysaccharide occurrence or abundance. The only viable option to precisely 
determine the binding epitopes of large numbers of the existing mAbs is to screen their 
binding capabilities with structurally well-defined oligosaccharides. Previous studies with cell 
wall-related oligosaccharides have demonstrated that glycan microarrays (Rillahan and 
Paulson 2011) can be used to determine the binding epitopes of cell wall glycan-directed 
mAbs (Pedersen et al. 2012; Schmidt et al. 2015). Synthetic chemistry is ideally suited to 
procure these well-defined oligosaccharides as it provides de novo designed oligosaccharides 
of exceptional purity. Herein, we report the production of a microarray equipped with 88 
synthetic oligosaccharides that enabled us to determine the binding epitopes of 78 plant cell 
wall glycan-directed mAbs. We further show that glycosyl hydrolases can be used on plant 
sections to specifically modify cell wall polysaccharides, generating new glycan epitopes that 
are detectable by specific mAbs. Integrating glycosyl hydrolases in immunological cell wall 
analyses thus provides additional structural information on plant cell wall polysaccharides. 
Results and Discussion 
Generation of a synthetic plant glycan microarray and determination of mAb epitopes 
We have chemically synthesized a library of plant cell wall derived oligosaccharides either 
using automated glycan assembly (compounds 1-66, Figure 1A) (Bartetzko et al. 2015; 
Bartetzko et al. 2017; Dallabernardina et al. 2016, 2017; Schmidt et al. 2015; Senf et al. 2017) 
or by conventional solution-phase chemistry (compounds 67-88, Figure 1A) (Andersen, Boos, 
et al. 2016; Andersen, Kracun, et al. 2016; Zakharova, Madsen, and Clausen 2013; Andersen 
2014). These include the following oligosaccharides; xylan oligosaccharides (compounds 1-
22) composed of a β-1,4-linked xylan backbone with arabinofuranose substitutions in the 2- 
and/or 3-position of the xylose residues or with glucuronic acid substitutions in the 2-position; 
glucan oligosaccharides (compounds 23-39) with a β-1,4-linked glucan backbone that can be 
substituted with α-1,6-linked xylose residues (xyloglucan, compounds 25-32) or interspersed 
with β-1,3-linkages (mixed-linkage glucans, MLGs, compounds 33-39); pectin derived 
oligosaccharides including β-1,4-linked type I (arabino-)galactans (compounds 40-49, 67-77, 
86-88) and a rhamnogalacturonan-I (RG-I) backbone oligosaccharide (compound 78); type II 
(arabino-)galactan oligosaccharides composed of a β-1,3-linked backbone branched with β-
1,6-linked galactan side chains that can be further substituted with α-1,3-linked 
arabinofuranoses or a terminal β-1,6-linked glucuronic acid (compounds 50-66, 79-85).  
The synthetic oligosaccharides were printed at four different concentrations on chemically 
activated glass slides using a non-contact piezoelectric microarray printer (Figure 1). This 
glycan array platform was used to systematically map the epitopes of 209 plant cell wall 
glycan-directed mAbs that were obtained from different laboratories. The binding strength of 
the mAbs to the printed oligosaccharides correlates with the fluorescence intensity observed 
for an individual interaction (Figure 1B, Supplementary Data File 1). To define a positive 
signal we required at least a 4-fold increase of signal intensity over background and a value of 
at least 4% of the maximal value for a particular antibody. The quantification of the binding 
strength of the xylan-directed mAb LM10 for the four different glycan printing concentrations 
is depicted in Figure 1C.  
We created a summarizing heatmap of the binding capabilities of individual mAbs and the 88 
different synthetic glycans (Figure 2A). Based on the binding patterns of the mAbs, we aimed 
to identify a common motif among the recognized oligosaccharides that represents the actual 
epitope. Several antibodies whose epitopes had been characterized in detail previously using 
defined oligosaccharides (Andersen, Boos, et al. 2016; Puhlmann et al. 1994; Willats, Marcus, 
and Knox 1998; Steffan et al. 1995) were included in our analysis. We were able to confirm 
the specificity of these mAbs, for example the binding of LM2 to glucuronic acid that is 
terminally attached to 1,6-linked galactan (Smallwood et al. 1996), and of LM6 and LM17 to 
1,5-linked arabinan (Verhertbruggen et al. 2009) (Figure 2B). Using the binding patterns of 
previously uncharacterized antibodies, we identified the binding epitopes for an additional 78 
mAbs (Figure 2B). To resolve similarities in the binding specificities of the mAbs, we used 
hierarchical clustering on the data obtained with arabinogalactan- (AG), xylan-, and 
xyloglucan-binding antibodies.  
Arabinogalactan-directed antibodies 
The hierarchical clustering identified three large groups of AG-binding antibodies among the 
antibodies tested. Based on the oligosaccharides bound we deduced that these three groups of 
antibodies bind to β-1,6-linked galactans that can be present in type I or type II (arabino-
)galactan. None of these antibodies bind to exclusively β-1,3-linked or β-1,4-linked galactans 
(Figure 2, Supplementary Figure 2A-C). This observation is consistent with previous ELISA 
experiments that revealed binding of these mAbs to diverse classes of polysaccharides, 
indicating the existence of these β-1,6-linked galactan epitopes in rhamnogalacturonan I, type 
II AG, and other pectic polysaccharide preparations from various plant sources (Pattathil et al. 
2010).  
While the binding pattern of these mAbs for the tested arabinogalactan oligosaccharides is 
largely similar, a major difference between these groups is their binding properties to 
oligosaccharides 53, 60, and 62. AG group 1 antibodies bind strongly, AG group 3 antibodies 
bind weakly, and AG group 2 antibodies do not bind to these oligosaccharides at all (Figure 
2A, Supplementary Figure 2A-C). In these three oligosaccharides the “lower” galactose of a 
β-1,6-linked galactan disaccharide epitope is substituted in the 3-position either with 
galactose or with arabinose. The antibody groups may be further distinguished based on their 
binding to oligosaccharide 74. The AG group 1 antibodies bind to oligosaccharide 74, while 
AG groups 2 and 3 do not. In oligosaccharide 74, the “upper” galactose residue of a β-1,6-
linked galactan disaccharide epitope is substituted at the C4-position. Based on the 
oligosaccharides tested, we conclude that AG group 2 antibodies bind to a minimal epitope of 
a β-1,6-linked disaccharide and the “lower” galactose may be part of a β-1,4-linked galactan 
backbone. The minimal epitope for the AG group 1 and 3 antibodies cannot be delineated 
completely with the oligosaccharides tested, although it appears that AG group 1 and 3 
antibodies bind to a β-1,6-linked disaccharide of which the “lower” galactose can be part of 
both a β-1,3-linked and β-1,4-linked galactan backbone (as for example in oligosaccharides 
53 and 72). Unlike AG group 3 antibodies, AG group 1 antibodies tolerate a substitution at 
the 4-position on the “upper” galactose. 
More differentiated binding patterns to arabinogalactans were observed for antibodies JIM14 
and JIM16. The binding pattern JIM14 revealed that at least three consecutive β-1,6-linked 
galactose units are required for binding (Figure 2A, Supplementary Figure 2D). Arabinose 
substitution at the central galactose unit did not affect binding, indicating that also 
arabinosylated galactan polysaccharides can be recognized by JIM14. However, lack of 
binding to compound 64 showed that the third galactose towards the non-reducing terminus 
must not be arabinosylated. To investigate if JIM14 binds an internal epitope or the non-
reducing end of β-1,6-galactans, we synthesized two glycans that do not permit binding to the 
terminal galactose unit (compounds 65 and 66). Based on JIM14 binding to compounds 65 
and 66, we conclude that JIM14 binds an internal epitope on β-1,6-linked galactans. JIM16 on 
the other hand recognizes a β-1,3-linked galactan backbone when substituted with a single β-
1,6-linked galactose residue (Figure 2B) as this antibody bound strongly only to compounds 
53 and 61 (Figure 2A). 
We identified an antibody that specifically recognizes the β-1,3-linked galactan backbone in 
AGs. JIM133 selectively binds all tested β-1,3-linked galacto-oligosaccharides, with tolerance 
for various β-1,6-linked arabinose and galactose substitutions. The strongly reduced binding 
of JIM133 to compound 57 compared to compound 50 indicates that this antibody requires 
the free non-reducing end of the galactan for binding. JIM133 can thus be used to detect the 
non-reducing ends of the β-1,3-linked galactan backbone in AG structures of AGPs. 
We identified two antibodies in addition to the previously characterized LM5 antibody (Jones, 
Seymour, and Knox 1997; Andersen, Boos, et al. 2016) that recognize β-1,4-linked type I 
galactan, a prominent side chain in RG I. CCRC-M107 requires a minimum of DP (degree of 
polymerization) = 4 (Supplementary Figure 2E, compounds 41, 42, 68-71). In contrast, 
CCRC-M133 only binds to β-1,4-linked galactan with DP = 6 or greater (Supplementary 
Figure 2F, compounds 42, 70, 71). Their strong binding to oligosaccharide 77 indicates that 
CCRC-M107 and CCRC-M133 bind to internal parts of type I galactan. Our results further 
show that CCRC-M107 tolerates limited arabinose substitution, whereas CCRC-M133 does 
not bind to any substituted β-1,4-linked galacto-oligosaccharides tested here.  
Xylan-directed antibodies 
We identified xylan-directed mAbs that cover most epitopes found in natural xylans. 
Antibodies in xylan group 1 recognize low-substituted xylans, tolerating to varying degrees 
different patterns of limited arabinose substitution (Figure 2). These mAbs bind strongly to 
oligosaccharides 3 and 4, indicating that longer stretches of β-1,4 xylan backbone represent 
the preferred epitope for these antibodies. Weak binding to substituted xylan oligosaccharides 
was also observed, e.g. oligosaccharides 9, 12, and 15. However, the available 
oligosaccharides do not permit an exhaustive determination of the tolerated substitution 
patterns. The xylan group 1 antibodies with the least tolerance for arabinose substitution of 
the backbone are CCRC-M140, CCRC-M160, CCRC-M137, and CCRC-M139. CCRC-M152 
stands out from the xylan 1 group by the observation that this antibody binds more strongly to 
oligosaccharide 9 than to oligosaccharide 14, which is different from the binding pattern of 
the remaining xylan group 1 antibodies. Contrary to these xylan group 1 mAbs, we found 
LM11, CCRC-M147, and CCRC-M149 to bind the β-1,4-linked xylan backbone with a high 
tolerance for backbone substitution. With slight differences in the binding patterns, most 
arabinose-substituted xylan oligosaccharides were recognized. 
In addition to these mAbs that recognize the xylan backbone, we also identified several mAbs 
that specifically detect distinct substituents present on xylan polymers, and do not bind to 
unsubstituted xylan oligosaccharides (compounds 1-4). For example, we found that CCRC-
M154 selectively binds to xylan oligosaccharides with an arabinose substitution in the 3-
position. However, compound 18 with two arabinose substituents linked to the same xylose 
residue was not recognized. On the other hand, we found that CCRC-M108, CCRC-M109, 
and CCRC-M110 specifically bind to xylan oligosaccharides with arabinose in the 2-position 
(Figure 2). Interestingly, CCRC-M108, CCRC-M109, and CCRC-M110, specific for 2-
substituted arabinoxylans, were all raised against Phormium tenax (New Zealand flax) and 
had been shown to bind exclusively to isolated Phormium xylan and not to xylans from other 
plants in ELISA experiments carried out with polysaccharide ligands (Pattathil et al. 2010). 
Thus, 2-substituted arabinoxylans might be specific to certain plants, although 
monosaccharide linkage analyses have previously suggested a broader occurrence of single 
arabinose substitution in the 2-position of xylans (Izydorczyk and Biliaderis 1995). 
Furthermore, we confirm binding of LM28 to xylan oligosaccharides substituted with 
glucuronic acid in the 2-position (Cornuault et al. 2015). While LM28 binds both methylated 
and unmethylated glucuronic acid side chains, we here identify mAbs that exclusively bind to 
either unmethylated glucuronic acid [CCRC-M150, a correction of previously published data; 
(Schmidt et al. 2015)] or 4-O-methyl glucuronic acid (CCRC-M144, CCRC-M145, CCRC-
M146, CCRC-M155). None of these antibodies bind to the glucose substituted compound 22, 
demonstrating that the carboxyl group is essential for binding of these mAbs. Since our 
collection did not contain esterified xylan oligosaccharides, we were not able to detect 
antibodies that recognize these epitopes. While LM12 binds to ferulated xylans (Pedersen et 
al. 2012), antibodies specifically recognizing acetylated xylan are yet to be developed. 
The most unexpected result was obtained for LM10, as this frequently used antibody was 
previously thought to bind low or un-substituted xylan (McCartney, Marcus, and Knox 2005). 
The glycan microarray experiments show that LM10 binds to all xylan oligosaccharides tested 
except compounds 10, 13, 14, and 19 (Figure 1B, C). These compounds are all substituted 
with arabinose either at the 2- or 3-position of the terminal xylose residue. While a lack of 
binding to compounds 10, 13, and 19 could still be explained by their relatively high 
arabinose content, absence of binding to compound 14, which was specifically designed to 
characterize this antibody, unequivocally established that LM10 binds to the non-reducing 
end of xylans. Similar results were obtained for AX1, X3, and LM23 which also bind to 
terminal xylose residues but tolerate slightly different substitution patterns. 
Intriguingly, all antibodies that bind the non-reducing end were raised against short 
oligosaccharides as immunogens, except for JIM133. All mAbs that were raised against 
polysaccharide antigens (72 of 78 mAbs) recognized an internal epitope within the polymer. 
These observations have important implications for the choice of oligosaccharide antigens to 
be used for the generation of new cell wall directed antibodies. Instead of internal sequences 
of complex polymers such as rhamnogalacturonan II, rather terminal oligosaccharides should 
be used as immunogens. 
Xyloglucan-directed antibodies  
Many mAbs have been raised against xyloglucan using either oligosaccharides (e.g. LM15 
and LM25 (Pedersen et al. 2012; Marcus et al. 2008) or polysaccharides (e.g. CCRC-M86, 
CCRC-M100, CCRC-M103) as antigens (Pattathil et al. 2010). The majority of these mAbs 
did not bind to any of our compounds (Supplementary Data File 1), probably because these 
antibodies require galactose or fucose substitutions for binding which are not included in our 
xyloglucan oligosaccharide library. Here, we could determine the epitopes for five xyloglucan 
antibodies. These xyloglucan-directed antibodies recognize a xyloglucan epitope with at least 
one α-1,6-linked xylose residue linked to a β-1,4-linked glucan backbone (no binding to 
unsubstituted β-1,4-linked glucan oligosaccharides 23 and 24 was observed, see Figure 2). 
While we could not derive whether LM25 binds to terminal or internal parts of xyloglucan, 
this distinction was possible for LM15 and CCRC-M103 (similarly CCRC-M86 and CCRC-
M100). We observed similar binding patterns for these antibodies except for the fact that 
LM15 does not bind to compound 28, whereas CCRC-M103 does not bind to compound 29 
(Figure 2A, Supplementary Figure 2G, H). Compound 28 is an elongated version of 
compound 25 with one additional glucose unit at the non-reducing end. This additional 
glucose abolished binding of LM15, suggesting that LM15 only tolerates a single 
unsubstituted backbone glucosyl residue at the non-reducing end of the oligosaccharide. 
Based on the importance of the non-reducing end of the oligosaccharides (25 vs 28) for 
binding we conclude that LM15 is directed towards the non-reducing end, with the 
requirement for the second last glucose to be substituted with an α-1,6-linked xylose. 
Contrary to LM15, CCRC-M103 binds more strongly to compound 28 compared to 
compound 25, suggesting that CCRC-M103 probably binds to internal parts of xyloglucan. 
The binding of CCRC-M103 to compounds 25, 27, 28, and 30-32 and the lack of binding to 
compounds 26 and 29 further suggest that CCRC-M103 requires a free glucose at the position 
next to the xylose substituent towards the non-reducing end. 
Rhamnogalacturonan I-directed antibodies 
Six antibodies directed at the backbone of RG-I were detected (Figure 2). For antibodies 
CCRC-M14, CCRC-M35, CCRC-M36, and CCRC-M69, indirect evidence suggested that 
they bind the backbone of RG-I (Pattathil et al. 2010), but definitive proof was missing. In 
addition, we could confirm the previously published binding epitope for INRA-RU1 and 
INRA-RU2, which was determined using purified rhamnogalacturonan oligosaccharides in 
competitive ELISA experiments (Ralet et al. 2010). 
Glycosyl hydrolase digests on the glycan microarray 
Next, we investigated if the immobilized glycans can be modified on the array using 
carbohydrate-active enzymes. Incubation of the microarray slides with arabinofuranosidases 
acting on arabinoxylan results in de-arabinosylation of the xylan oligosaccharides, as detected 
with xylan-directed mAbs LM10, CCRC-M154, and the xylan group 1 antibody CCRC-M148 
(Figure 3A, B). As expected, CCRC-M148 now recognized oligosaccharides that were 
previously too heavily arabinosylated to permit binding of this antibody. For example, 
oligosaccharide 8 was bound after de-arabinosylation (Figure 3 A, B), suggesting that CCRC-
M148 binds to unsubstituted xylan backbones of DP = 5 or greater, a refinement of previous 
characterization data for this antibody which indicated CCRC-M148 binding to xylan 
oligosaccharides of DP = 6 or greater (Schmidt et al. 2015). The binding of CCRC-M154, 
which is selective for 3-substituted arabinofuranoses, was strongly reduced after 
arabinofuranosidase treatment. Restoration of LM10 binding to oligosaccharides with an 
arabinose attached to the non-reducing xylose unit (compounds 10, 13, and 14) upon de-
arabinosylation further confirmed the proposed binding mode of LM10 directed at the non-
reducing end of xylans. 
As a second example, we used a β-1,6-endogalactanase (Kitazawa et al. 2013; Kotake et al. 
2004) to trim the side chains of synthetic AG oligosaccharides. This endogalactanase was 
reported to hydrolyze β-1,6-linked galactan side chains of AGP polysaccharides until one or 
two galactose residues remain on the β-1,3-linked galactan backbone (Kitazawa et al. 2013). 
Binding of JIM14, which recognizes glycans with at least three consecutive β-1,6-linked 
galactose residues (Figure 2B), was abolished upon treatment with β-1,6-endogalactanase for 
all synthetic galactan oligosaccharides that were not substituted with arabinose at the central 
galactose unit (oligosaccharides 52, 56, 65 and 66), but not for the oligosaccharides that were 
arabinosylated (59 and 63, Figure 3C, D). To remove the arabinoses from oligosaccharides 59 
and 63, we used an arabinofuranosidase and unexpectedly found slightly reduced binding of 
JIM14 to oligosaccharides 56, 59, and 63, probably due to traces of galactanase activity in the 
enzyme preparation. However, when both arabinofuranosidase and galactanase were applied 
together on the glycan microarray, recognition of oligosaccharides 59 and 63 was completely 
abolished (Figure 3C, D). This indicated that the galactanase only tolerates arabinose 
substitution in certain positions of the galactan to be hydrolyzed. JIM16 recognizes the 1,3-
linked galactan backbone when substituted with a single 1,6-linked galactose residue (Figure 
2B). Binding of JIM16 to oligosaccharide 56 after galactanase digestion and oligosaccharide 
63 after arabinofuranosidase and galactanase digestion confirmed that a single 1,6-linked 
galactose unit remained on the 1,3-linked backbone of these oligosaccharides (Figure 3D). 
Although exact substrate specificities of glycosyl hydrolases acting on cell wall glycans can 
only be determined by structural characterization of the reaction products after incubation of 
oligo- or polysaccharides, these data demonstrate that the synthetic plant glycan microarray 
platform provides a useful tool, in combination with well-characterized mAbs, to collect 
valuable information on the substrate specificities of glycosyl hydrolases in a high-throughput 
fashion. As our platform provides specific information on the enzyme’s substrate specificities, 
it represents a powerful extension of previous polysaccharide-based array platforms for the 
identification of new glycosyl hydrolases (Vidal-Melgosa et al. 2015; Walker et al. 2017). 
Implementation of glycosyl hydrolases into cell wall labeling studies 
Specific knowledge of the molecular structure bound by a particular mAb and the substrate 
specificities of glycosyl hydrolases acting on the very same polysaccharide allows for a 
detailed immunological elucidation of glycan structures in the cell wall. We performed 
antibody staining of xylans and AGs in roots of Brachypodium distachyon (Brachypodium), 
which is a model system to study grass roots (Hardtke and Pacheco-Villalobos 2015). We 
used CCRC-M148 to detect unsubstituted xylan stretches, CCRC-M154 to identify 
arabinosylated xylan, and LM10 to specifically track the non-reducing ends of xylan polymers 
(Figure 4). Interestingly, these three mAbs showed distinct binding patterns on sections of the 
root elongation zone. CCRC-M148 bound to walls of all cells of the stele (central metaxylem 
to pericycle cells), CCRC-M154 bound to walls of cells in the stele and in the surrounding 
cortex, and LM10 selectively bound to walls of pericycle and metaxylem cells. Thus, the 
secondary cell walls in the stele contain xylans with a low degree of arabinosylation, whereas 
the primary walls in cortex cells contain only highly arabinosylated xylans (Christensen et al. 
2010). To confirm that the binding of CCRC-M154 to the cortex cells results from their high 
arabinoxylan content, we applied arabinoxylan-specific arabinofuranosidases (McCleary et al. 
2015) to the sections prior to antibody staining. Indeed, CCRC-M154 binding was completely 
abolished in all cell walls, while CCRC-M148 now also bound to the cortex cell walls in 
addition to the stele walls. Apparently, de-arabinosylating the xylan exposed unsubstituted 
xylan stretches for CCRC-M148 binding in cortex cell walls. LM10 binding was not affected 
by arabinofuranosidase treatment, suggesting that arabinosylation of the terminal xylose unit 
of the xylan chain was not causative for the observed differential binding of LM10 to the 
walls of different cell types. Instead, we hypothesize that the non-reducing ends of the xylan 
chains are covalently modified or covered by interactions with other components of the cell 
wall matrix. 
JIM14 and JIM16 represent an interesting pair of antibodies to visualize differentially 
branched galactan in type II AG-polysaccharides that are present on arabinogalactan proteins 
(AGPs; Figure 4). Yariv stain-based localization of AGPs showed that all cells in the root 
sections contained AGPs in their cell wall (Supplementary Figure 3). Lack of JIM16 binding 
to these root sections suggests that the AG-structures contain no single β-1,6-linked galactose 
substitutions of the backbone but rather longer galactan side branches. However, only 
metaphloem cells were stained by JIM14. We hypothesized that all other cells might display 
higher degrees of arabinosylation than recognizable by JIM14. To test this hypothesis, we 
incubated the sections with arabinofuranosidase prior to antibody staining. Indeed, de-
arabinosylation resulted in JIM14 binding to all cells. As we were able to convert the JIM14 
epitope into the JIM16 epitope by enzymatically trimming the β-1,6-linked galactan side 
chains on the microarray (Figure 3C, D), we tested if the JIM16 epitope could be revealed in 
the root sections as well. We incubated the sections with the β-1,6-galactanase that was used 
on the microarray, but did not observe any JIM16 binding upon subsequent antibody staining. 
Only when both arabinofuranosidase and β-1,6-galactanase were applied together prior to 
antibody staining was the JIM16 epitope revealed in all root cells. Apparently, the 
metaphloem cells contain at least some arabinose substitution, which inhibited complete 
enzymatic cleavage of the β-1,6-linked galactan branches. Thus, we conclude that the AG-
structures in metaphloem cells contain a low degree of arabinosylation, whereas all other root 
cells display highly arabinosylated AGPs. The complexity of the AG-structure in AGPs has 
previously been associated with growth phenotypes in Brachypodium mutants and an 
Arabidopsis mutant (Knoch et al. 2013; Pacheco-Villalobos et al. 2016). Both studies used 
glycosidic linkage analyses on whole roots or root segments to show differences in type II AG 
related galactose linkages (Knoch et al. 2013; Pacheco-Villalobos et al. 2016). To resolve 
which cell types display the differences in AGP complexity, more detailed analyses are now 
feasible based on the newly derived epitope information for type II AG-specific antibodies 
and the possibility for integrating specific glycosyl hydrolases into cell wall analyses. 
It is important to note that integrating glycosyl hydrolases to specifically reveal antibody 
epitopes is different to previous studies, in which plant sections were pre-treated with a 
pectate lyase (Herve et al. 2009; Marcus et al. 2008; Marcus et al. 2010) to unmask xylan, 
xyloglucan, and mannan epitopes (Herve et al. 2009; Marcus et al. 2008; Marcus et al. 2010). 
The rational use of glycosyl hydrolases to alter the molecular structure of specific cell wall 
glycans provides additional structural information on the respective glycan. As this approach 
is limited by the availability of glycosyl hydrolases and antibodies with precisely known 
specificities, further expansion of the repertoire of suitable enzymes and antibodies will be 
crucial. This is particularly important as we cannot fully rule out the possibility that, in cases 
where glycosyl hydrolases with broader substrate specificities are used, multiple cell wall 
glycans may be affected, and this may lead to masking or de-masking of epitopes. 
Conclusions 
Using a synthetic plant carbohydrate microarray, we determined the binding epitopes for a 
large number of plant cell wall glycan-directed mAbs, providing the required information for 
the specific detection of many complex molecular structures in plant cell wall 
polysaccharides. We further demonstrate that integrating specific glycosyl hydrolases with 
immunolabeling studies of cell walls enables an even more comprehensive analysis of 
distribution patterns of cell wall glycans in plant cells. Our integrated mAb-based analyses 
provided detailed information on glycan structures in roots of the important model grass 
species Brachypodium distachyon, highlighting the importance of structural understanding of 
epitopes for the comprehensive interpretation of in situ cell wall labeling studies. 
Methods 
Chemical synthesis of oligosaccharides 
Compounds 1-66 were prepared by automated glycan assembly following previously 
published protocols (Bartetzko et al. 2015; Bartetzko et al. 2017; Dallabernardina et al. 2016, 
2017; Schmidt et al. 2015; Senf et al. 2017). Briefly, using an automated synthesizer suitably 
protected monosaccharide building blocks were added in iterative glycosylation and 
deprotection cycles to a linker-functionalized Merrifield resin. After assembly was complete, 
the linker was cleaved and the oligosaccharides were globally deprotected to yield the desired 
glycans after HPLC-purification. Compounds 67-88 were prepared by conventional solution-
phase synthesis (Andersen, Boos, et al. 2016; Andersen, Kracun, et al. 2016; Zakharova, 
Madsen, and Clausen 2013; Andersen 2014). 
Glycan microarray printing 
The oligosaccharides were printed on CodeLink N-hydroxyl succinimide (NHS) ester-
activated glass slides (SurModics Inc., Eden Prairie, MN, USA) using a non-contact 
piezoelectric spotting device (S3; Scienion, Berlin, Germany). The printing was performed at 
room temperature and 40% humidity. To ensure constant printing efficiency, the first 
compound (oligosaccharide 1) was reprinted at the end of the printing run. To assess the 
binding strength of the antibodies, we diluted the oligosaccharides to four different printing 
concentrations (200 μM, 50 μM, 12.5 µM, and 3.1 µM) in the coupling buffer (80% (v/v) 50 
mM sodium phosphate, pH 8.5, 0.005% (v/v) CHAPS, 20% (w/v) PEG400 (Roth)). After 
printing, the microarray slides were quenched for 1 h at room temperature in 100 mM 
ethanolamine, 50 mM sodium phosphate, pH 9, and washed three times with deionized water. 
Determining mAb epitopes  
We obtained mAbs from different sources as indicated in Supplementary Data File 1, i.e. the 
Complex Carbohydrate Research Center (CCRC), University of Leeds, the INRA in Nantes, 
the Classen lab at the University of Kiel, and the University of Melbourne. To incubate 16 
different antibodies per microarray slide we applied a FlexWell 16 grid (Grace Bio-Labs, 
Bend, OR, USA) to the slide. The slides were blocked with 1% (w/v) bovine serum albumin 
(BSA) in phosphate-buffered saline (PBS) for 1 h at room temperature. Then, hybridoma 
supernatants containing the antibodies were diluted 1:10 in PBS containing 1% (w/v) BSA 
and incubated for 1 h on the slides. After three washes with PBS, the slides were incubated 
with the respective secondary antibodies for 1 h (goat anti-rat IgG AF555 and goat anti-mouse 
IgM/IgG AF488, Invitrogen, Carlsbad, CA, USA). Unbound secondary antibodies were 
removed using consecutive washes with 0.1% (v/v) Tween-20 in PBS, PBS, and deionized 
water. After drying the slides by centrifugation (300 x g, 2 min), the fluorescent signal on the 
slides was scanned with a GenePix 4300A microarray scanner (Molecular Devices, 
Sunnyvale, CA, USA). Image analysis and quantification of the fluorescent signal was carried 
out with the GenePix Pro 7 software (Molecular Devices) using the same settings for each 
antibody. Based on the raw data (Supplementary Data File 1), we defined positive signals for 
each of the four printed glycan concentrations based on two thresholds that we cross-validated 
using antibody binding to known epitopes: (i) 4-fold increase of fluorescent signal intensity 
over background and (ii) a fold-change value of at least 4 % of the maximal value of the 
respective antibody. The resulting numbers of 0–4 therefore indicate the minimum printing 
concentrations (0 = no binding, 1 = 200 μM, 2 = 50 μM, 3 = 12.5 µM, and 4 = 3.1 µM) 
required for binding of an antibody. To group similar antibodies we separately performed 
hierarchical clustering on AG-, xylan-, and xyloglucan-binding antibodies. To this end, we 
applied the “hclust” function in R using manhattan distance as a distance measure.  
Glycosyl hydrolase digests on glycan microarrays 
For the arabinoxylan digests, we used two GH43 arabinofuranosidases from Bacteroides 
ovatus (ABFBO17 and ABFBO25) that were purchased from Megazyme (Bray, Ireland). 
ABFBO17 removes arabinose substituents linked to the 3-position of double-substituted 
xylose residues, whereas ABFBO25 cleaves single arabinoses in the C2- and C3-position of 
xylose (Senf et al. 2017). The enzymes were used at a concentration of 10 U/ml in 100 mM 
sodium phosphate buffer, pH 6.5. For the AG digests, we used a GH51 arabinofuranosidase 
from Aspergillus niger (AFASE) purchased from Megazyme at a concentration of 0.1 U/ml 
and an endo-1,6-galactanase from Trichoderma viride (Tv6GAL) at a concentration of 5 
U/ml, both in sodium citrate buffer, pH 4.5. Tv6GAL was expressed recombinantly in Pichia 
pastoris as previously described (Kotake et al. 2004). In both arabinoxylan and AG digests, 
the enzymes were applied directly in the 16 well grid of a microarray slide and incubated over 
night at 37°C. The corresponding buffers without enzymes were used as controls. After 
washing the slides twice with PBS, blocking and antibody staining were performed as 
described above. Secondary antibodies used were goat anti-rat IgG AF555 for LM10, JIM14, 
and JIM16, and goat anti-mouse IgM AF594 for CCRC-M148 and CCRC-M154. The 
fluorescent signal was recorded with a GenePix 4300A microarray scanner and quantified 
with the GenePix Pro 7 software. 
Immunofluorescence analysis of Brachypodium root sections 
To analyze arabinoxylan and AG-structures in Brachypodium roots, we grew Brachypodium 
(accession Bd21) on vertical MS agar plates under 16 h light/8 h dark cycles. Root tips were 
harvested four days after germination and fixed for 1 h in a 2.5% (v/v) glutaraldehyde 
solution. Dehydration and embedding into LR White was performed as previously described 
(Lee et al. 2012). The root tips were cut into 1 µm sections using a Leica Ultracut UCT 
ultramicrotome. The antibody staining was performed as described for the glycan microarray 
experiments using goat anti-rat IgG AF555 for LM10, JIM14, and JIM16, and goat anti-
mouse IgM AF594 for CCRC-M148 and CCRC-M154. AGP-localization in the sections was 
carried out as previously described (Goellner, Gramann, and Classen 2013). In brief, after 
blocking the sections with BSA-buffer, (β-D-Glc)3 Yariv phenylglycoside (βGlcY, 400 µg/mL 
in 0.15 M NaCl) was applied for 90 min. After three washes with PBS, first a βGlcY-antibody 
and then the corresponding FITC-labelled anti-rabbit secondary antibody were incubated on 
the sections. Imaging was carried out with a LSM700 confocal microscope (Zeiss, Jena, 
Germany). Glycosyl hydrolase digests of arabinoxylan and AG in the sections were 
performed using the same enzymes and conditions as for the digests on the glycan microarray.  
Supplemental Materials 
Supplementary Figure 1. Summarizing heatmap of binding interactions between individual 
mAbs and synthetic glycans. 
Supplementary Figure 2. Selected glycan microarray scans. 
Supplementary Figure 3. Yariv-based staining of AGPs in Brachypodium root sections and 
antibody staining negative controls. 
Supplementary Data File 1. Quantification of the fluorescence signals (raw data) for all tested 
antibodies. 
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Figure legends 
Figure 1. A glycan microarray equipped with synthetic cell wall oligosaccharides.  
(A) The printed oligosaccharides comprise fragments of four major polysaccharide classes: xylans (compounds 
1-22), glucans (23-39), galactans (40-77, 79-88), and rhamnogalacturonan-I (78). Red and black bars at the 
reducing end of the oligosaccharides indicate the different linkers of the respective compounds produced either 
by automated glycan assembly (1-66) or conventional solution-phase chemistry (67-88). The legend for linkage 
types denotes at which position the next monosaccharide is attached. (B) Fluorescence signal for binding of 
LM10 to xylan oligosaccharides. Each compound was printed at four different concentrations as indicated on the 
right. The printing pattern of the glycan microarray is depicted in C. (C) Quantification of the fluorescence 
signal for LM10. The values denote fold-change over background. Only signals of more than 4-fold above 
background and above 4% of the maximal value are shown. Note that the 200µM and the 50µM concentrations 
of oligosaccharide 1 were reprinted on the array as the last spots (lower right corner) to confirm constant printing 
efficiency. 
Figure 2. Identification of plant cell wall mAb epitopes.  
(A) Heatmaps of the binding interactions between individual mAbs and respective synthetic glycans. The 
binding strength of an antibody to a compound is visualized by a color code (0-4) which denotes how many of 
the four printed glycan concentrations displayed a positive fluorescence signal. Antibodies were grouped based 
on hierarchical clustering. The representative result of three replicates is shown. The full heatmap is shown in 
Supplementary Figure 1. (B) Identified epitopes of cell wall-directed antibodies. Linkages that are marked with a 
red bar indicate positions that must not be occupied. Light linkages and light monosaccharide symbols indicate 
positions for substitutions that are allowed but not required for binding. For antibodies depicted in bold, no or 
very limited epitope information was available previously. Note that mAbs of xylan group 1 tolerate different 
degrees of low-level substitution of the xylan backbone. 
Figure 3. The glycan microarray as a platform to characterize glycosyl hydrolases.  
(A) “On-array” treatment of xylan oligosaccharides with arabinofuranosidases and assessment of arabinose 
cleavage with CCRC-M148, CCRC-M154, and LM10. Note that the 200 µM concentration for oligosaccharide 7 
was misprinted, resulting in a low signal intensity after quantification (see LM10). (B) Quantification of the 
fluorescence signal with and without arabinofuranosidase treatment as shown in A. (C) Arabinogalactan digest 
on the array with 1,6-galactanase and arabinofuranosidase detected with JIM14 and JIM16. (D) Quantification of 
the fluorescence signals in C. Representative results of three independent experiments are shown. 
Figure 4. Immunological analyses reveal detailed molecular glycan structures in Brachypodium root sections 
(A) Toluidine blue was used to stain sections and identify cell types (Hardtke and Pacheco-Villalobos 2015). (B) 
Immunolabelling of (arabino)xylan using CCRC-M148, CCRC-M154, and LM10 in root tips of Brachypodium. 
(C) Putative arabinogalactan (AG) side chains with expected binding of JIM14 and JIM16. (D) Immunolabelling 
of AG-structures using JIM14 and JIM16. Arabinofuranosidases and galactanases were incubated on the sections 
prior to the antibody staining to reveal xylan and galactan epitopes. The scale bars indicate 50 µm. 
Representative results of three independent biological replicates are shown. 
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